FAP in Focus Symposium Showcases Further Advances in FAP Targeting
June 5, 2026 – Five years after its inception, SOFIE’s FAP symposium continues to bring […]
FAPI Newsletter Q2 – 2026
A WORD FROM OUR CHIEF SCIENTIFIC OFFICER
We are in the midst of a productive […]
FAP in Focus – Oncology and Horizons Beyond Cancer
FAP in Focus – Oncology and Horizons Beyond Cancer
Satellite Symposium
SNMMI Annual Meeting
May 31, 2026 View […]
Safety of [68Ga]Ga-FAPI-46 PET/CT including hemodynamic measurements and patient-reported outcomes in cancer patients
Morten Bentestuen, Camilla Sylvest, Svend B Jensen, Lara R Soro, Aage Knudsen, Morten Ladekarl, Ole […]
A 3D co-culture model with fibroblast-restricted FAP expression for cancer therapy using [212Pb]Pb-FAPI-46
Sandra K Kristiansen, Nurtene Dernjani, Øyvind S Bruland, Nina Frederike J Edin, Asta Juzeniene
FAPI Newsletter Q1 – 2026
A WORD FROM OUR CHIEF SCIENTIFIC OFFICER
Dear FAPI […]
Ensuring enantiomeric consistency in FAPI radiopharmaceuticals
Magdalena Staniszewska, Ralph Hübner, Camilla Locatelli, Douglas Howard, Matilde Forni, Francis Man, Bent Wilhelm Schoultz, […]
90Y-FAPI-46 Radiopharmaceutical Therapy in Sarcoma and Other Solid Tumors: An Updated Cohort Analysis
Helena Lanzafame, Ilektra A. Mavroeidi, Kim M. Pabst, Pedro Fragoso Costa, Martin Schuler, Sebastian Bauer, […]
SOFIE Biosciences Announces First Patient Dosed in [18F]FAPI-74 Phase 3 Study for Pancreatic Cancer
- First dose at HOAG Health in FAPI-PRO trial for Pancreatic Ductal Adenocarcinoma
- A parallel […]
Revealing Reliability and Practicability of FAP-RADS Version 1.0 for Structured Reporting of FAPI Imaging in Pulmonary and Urothelial Carcinoma
Emil Novruzov, Eduards Mamlins, Liam Widjaja, Sophie C Siegmund, Tadashi Watabe, Yuriko Mori, Christian Stief, […]